Wim Martinet

27.4k total citations · 3 hit papers
209 papers, 10.4k citations indexed

About

Wim Martinet is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Wim Martinet has authored 209 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 69 papers in Epidemiology and 50 papers in Immunology. Recurrent topics in Wim Martinet's work include Autophagy in Disease and Therapy (55 papers), Atherosclerosis and Cardiovascular Diseases (24 papers) and Phagocytosis and Immune Regulation (23 papers). Wim Martinet is often cited by papers focused on Autophagy in Disease and Therapy (55 papers), Atherosclerosis and Cardiovascular Diseases (24 papers) and Phagocytosis and Immune Regulation (23 papers). Wim Martinet collaborates with scholars based in Belgium, Netherlands and France. Wim Martinet's co-authors include Guido R.Y. De Meyer, D. Schrijvers, Mark Kockx, Arnold G. Herman, Michiel Knaapen, Lynn Roth, Mandy O. J. Grootaert, Jean‐Pierre Timmermans, Ammar Kurdi and Hidde Bult and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Wim Martinet

208 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis

2018 434 citations Lynn Roth, Wim Martinet et al. profile →
Animal models of atherosclerosis

2017 407 citations Lynn Roth, Wim Martinet et al. profile →
Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets

2024 102 citations Guido R.Y. De Meyer, Pauline Puylaert et al. profile →

Peers

Countries citing papers authored by Wim Martinet

Since Specialization

Citations

This map shows the geographic impact of Wim Martinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Martinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Martinet more than expected).

Fields of papers citing papers by Wim Martinet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim Martinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Martinet. The network helps show where Wim Martinet may publish in the future.

Co-authorship network of co-authors of Wim Martinet

This figure shows the co-authorship network connecting the top 25 collaborators of Wim Martinet. A scholar is included among the top collaborators of Wim Martinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Martinet. Wim Martinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: evidence from a nationwide nested case–control study paralleled with matched experimental models 2025 ·European Heart Journal Open ·(unknown), Jarl Emanuel Strange, Anders Holt, Gunnar Gislason, (unknown), (unknown), (unknown), Mart Theunis, Tania Naessens, Lynn Roth, Guido R.Y. De Meyer, Wim Martinet, Peter Rasmussen, Pieter‐Jan Guns	1
2	Circulating autophagy regulator Rubicon is linked to increased myocardial infarction risk 2024 ·SHILAP Revista de lepidopterología ·Marie-Hélène Grazide, Jean‐Bernard Ruidavets, Wim Martinet, Meyer Elbaz, Cécile Vindis	2
3	GPX4 overexpression does not alter atherosclerotic plaque development in ApoE knock-out mice 2024 ·SHILAP Revista de lepidopterología ·(unknown), Annelies Breynaert, Nina Hermans, Guido R.Y. De Meyer, Wim Martinet	2
4	Unravelling the impact of active and passive contributors to arterial stiffness in male mice and their role in vascular aging 2024 ·Scientific Reports ·(unknown), (unknown), Guido R.Y. De Meyer, Wim Martinet, Pieter‐Jan Guns	1
5	Regulated Necrosis in Atherosclerosis 2022 ·Arteriosclerosis Thrombosis and Vascular Biology ·Pauline Puylaert, (unknown), Katey J. Rayner, Guido R.Y. De Meyer, Wim Martinet	63
6	Progressive aortic stiffness in aging C57Bl/6 mice displays altered contractile behaviour and extracellular matrix changes 2022 ·Communications Biology ·Sofie De Moudt, Jhana O. Hendrickx, (unknown), (unknown), Arthur Leloup, Guido R.Y. De Meyer, Wim Martinet, Paul Fransen	28
7	The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach 2022 ·Biomedicines ·Pauline Puylaert, (unknown), (unknown), Yves Dondelinger, Tom Delanghe, Mathieu J.M. Bertrand, Pieter‐Jan Guns, Guido R.Y. De Meyer, Wim Martinet	5
8	Disparate biomechanical properties of the aorta in non‐aneurysmal and aneurysmal mice treated with angiotensin II 2022 ·Physiological Reports ·Sofie De Moudt, Jhana O. Hendrickx, Guido R.Y. De Meyer, Wim Martinet, Paul Fransen	1
9	Mouse aortic biomechanics are affected by short-term defective autophagy in vascular smooth muscle cells 2022 ·The Journal of Physiological Sciences ·(unknown), Arthur Leloup, Sofie De Moudt, Guido R.Y. De Meyer, Wim Martinet, Paul Fransen	4
10	Coupling Additive Manufacturing with Hot Melt Extrusion Technologies to Validate a Ventilator-Associated Pneumonia Mouse Model 2021 ·Pharmaceutics ·Bahaa Shaqour, Juliana Aizawa, (unknown), (unknown), Lars Christophersen, Wim Martinet, Emilia Choińska, Martijn Riool, (unknown), Koen Beyers, Claus Moser, Wojciech Święszkowski, Sebastian A. J. Zaat, Paul Cos	8
11	Doxorubicin induces arterial stiffness: A comprehensive in vivo and ex vivo evaluation of vascular toxicity in mice 2021 ·Toxicology Letters ·(unknown), (unknown), (unknown), Griet Jacobs, Guido R.Y. De Meyer, Wim Martinet, Emeline M. Van Craenenbroeck, Pieter‐Jan Guns	27
12	Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wim Martinet, Guido R.Y. De Meyer, Emeline M. Van Craenenbroeck, Pieter‐Jan Guns	22
13	Autophagy Dynamics and Modulation in a Rat Model of Renal Ischemia-Reperfusion Injury 2020 ·International Journal of Molecular Sciences ·Jean-Paul Decuypere, Shawn Hutchinson, Diethard Monbaliu, Wim Martinet, Jacques Pirenne, Ina Jochmans	13
14	The Protective Effects of the Autophagic and Lysosomal Machinery in Vascular and Valvular Calcification: A Systematic Review 2020 ·International Journal of Molecular Sciences ·(unknown), Jhana O. Hendrickx, Wim Martinet, Guido R.Y. De Meyer, Pieter‐Jan Guns	10
15	Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity 2019 ·Virus Research ·(unknown), (unknown), (unknown), Wim Martinet, Guy Caljon, Louis Maes, Paul Cos, Peter Delputte	22
16	Patient Perceptions of Electronic Prescriptions in Belgium: An Exploratory Policy Analysis 2018 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Hilde Bastiaens, Wim Martinet, Hans De Loof	8
17	Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia 2017 ·Journal of Microbiological Methods ·(unknown), Davie Cappoen, (unknown), (unknown), (unknown), Tom Coenye, Wim Martinet, Guy Caljon, Louis Maes, Peter Delputte, Paul Cos	2
18	Angiotensin II increases coronary fibrosis, cardiac hypertrophy and the incidence of myocardial infarctions in ApoE^-/-Fbn1^C1039G+/- mice. 2016 ·PubMed ·Lynn Roth, D. Schrijvers, Wim Martinet, Guido R.Y. De Meyer	4
19	Molecular and cellular mechanisms of skeletal muscle atrophy: an update 2012 ·Journal of Cachexia Sarcopenia and Muscle ·Alessandro Fanzani, Viviane M. Conraads, Fabio Penna, Wim Martinet	272
20	Immunohistostaining Assays for Detection of Chlamydia pneumoniae in Atherosclerotic Arteries Indicate Cross-Reactions with Nonchlamydial Plaque Constituents 2004 ·Journal of Clinical Microbiology ·Vicky Y. Hoymans, Johan Bosmans, D. Ursi, Wim Martinet, Floris L. Wuyts, Eric Van Marck, Martin Altwegg, Christiaan Vrints, Margareta Ieven	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact